The Canadian Cancer Clinical Trials Network
The Canadian Cancer Clinical Trials Network (3CTN) is a pan-Canadian initiative to improve the efficiency and quality of clinical trials in Canada. 3CTN will provide support and coordination for a network of teams at cancer treatment centres and hospitals. With regional participation, 3CTN will enable sites to increase their capacity and capability to conduct academic trials.
2015 NACC Request for Applications
3CTN is issuing a Request for Application (RFA) for Network Affiliated Cancer Centres (NACC) that have been identified on successful Network Cancer Centers (NCC) applications as affiliated centres and/or centres with the potential to be a NACC. The successful NACC applicants will work with their respective NCC to implement activities and address impediments to patient access and the execution of academic cancer clinical trials. All NACCs will play an important part in the Network to support and improve the efficient delivery of academic sponsored cancer clinical trials within their institution and their local-regional clinical trials node.
To respond to this RFA, review the NACC RFA guidelines and complete the NACC application forms. Deadline for submission to email@example.com is May 1, 2015.
Prostate Cancer Initiative
The Canadian Cancer Clinical Trials Network(3CTN) is pleased to issue the following request for concept proposals for clinical research projects in prostate cancer. Prostate cancer is the most common cancer to affect Canadian men. One in seven men will be diagnosed with the disease in their lifetime. This year Janssen Inc. has provided $500,000 to support clinical research proposals that address important clinical questions. Proposals may include evaluations of biospecimens from previously conducted clinical trials, support conduct of clinical trials or the evaluation of public databases or registries.
The identification of proposals and distribution of funds will be through 3CTN. The process for proposal development and evaluation is as follows:
1. a written concept, maximum 2 pages will be submitted electronically to 3CTN. (2) A short presentation (for each concept proposal submitted) will be made during a special session May 2, 2015 (exact time to be announced) at the Eaton Chelsea, Toronto. This session will be held during the NCIC CTG annual spring meeting to facilitate the attendance and participation of interested investigators. (3) Concepts accepted for moving forward to full application will be notified following the presentations after the NCIC-CTG meeting.
clinical trials and clinical research studies in prostate cancer.
$500,000 total over 3 years
Key Dates & Contact Information:
|Issue of Request of Concept proposals||March 20, 2015|
|Concepts Due Date||April 17, 2015|
|Presentation Meeting||May 2, 2015|
|Notification of Acceptance to Full Application||May 11, 2015|
|Full Application Due Date||August 31, 2015|
|Review Period||September, 2015|
|Notification of Award||October 31, 2015|
|Award Period||October 31 2015 to September, 2018|
|Application Submission Contact||Karen Arts, Executive Director, 3CTN
|Budget Contact||Saher Lalani, Project Financial Analyst 3CTN|
Canadian Cancer Clinical Trials Network receives new funding, launches online service to connect patients to clinical trials.
April 15, 2015
3CTN has released its April Newsletter. View this issue for more information on 3CTN Progress to date.